Mural Oncology plc (MURA)
NASDAQ: MURA · Real-Time Price · USD
2.040
0.00 (-0.01%)
Dec 5, 2025, 4:00 PM EST - Market closed
Mural Oncology Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Net Income | -119.1 | -128.51 | -207.45 | -189.81 | -175.43 |
| Depreciation & Amortization | 3.66 | 3.51 | 2.57 | 1.54 | 1.47 |
| Loss (Gain) From Sale of Assets | 3.34 | 0.1 | - | - | - |
| Asset Writedown & Restructuring Costs | 0.92 | 0.92 | - | - | - |
| Loss (Gain) From Sale of Investments | -0.73 | -3.6 | - | - | - |
| Stock-Based Compensation | 0.16 | 5.08 | 24.11 | 11.93 | 11.5 |
| Change in Accounts Receivable | 1.39 | 5.5 | - | - | - |
| Change in Accounts Payable | -12.64 | -2.43 | -18.25 | 8.39 | 5.52 |
| Change in Other Net Operating Assets | 2.03 | -9.12 | 4.77 | -0.64 | 0.27 |
| Operating Cash Flow | -118.41 | -128.55 | -194.25 | -168.59 | -156.67 |
| Capital Expenditures | -0.04 | -0.09 | -3.45 | -5.51 | -4.39 |
| Sale of Property, Plant & Equipment | 0.85 | 0.07 | - | - | - |
| Investment in Securities | 65.17 | -25.31 | - | - | - |
| Investing Cash Flow | 65.98 | -25.33 | -3.45 | -5.51 | -4.39 |
| Issuance of Common Stock | 0.03 | 0.2 | - | - | - |
| Other Financing Activities | - | - | 468.81 | 174.1 | 161.05 |
| Financing Cash Flow | 0.03 | 0.2 | 468.81 | 174.1 | 161.05 |
| Net Cash Flow | -52.41 | -153.68 | 271.11 | - | - |
| Free Cash Flow | -118.45 | -128.64 | -197.7 | -174.1 | -161.05 |
| Free Cash Flow Per Share | -6.88 | -7.59 | -11.85 | -10.43 | - |
| Levered Free Cash Flow | -69.64 | -82.24 | -113.89 | -99.81 | - |
| Unlevered Free Cash Flow | -69.64 | -82.24 | -113.89 | -99.81 | - |
| Change in Working Capital | -9.21 | -6.05 | -13.48 | 7.75 | 5.79 |
Source: S&P Capital IQ. Standard template.
Financial Sources.